CausalSentinel

Protein Dossier — NCAM1 (Neural cell adhesion molecule 1)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Pancreatic cancer 1.65 0.441 1.80e-04 Wald ratio 1 trans NA
Bipolar disorder -0.222 0.0727 0.00221 Inverse variance weighted 2 trans NA
Bipolar disorder -0.222 0.0727 0.00221 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: K60 Fissure and fistula of anal and rectal regions -0.00152 0.000545 0.00539 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: K60 Fissure and fistula of anal and rectal regions -0.00152 0.000545 0.00539 Inverse variance weighted 2 cis NA
Systolic blood pressure automated reading 0.0222 0.00807 0.00603 Inverse variance weighted 2 trans NA
Systolic blood pressure automated reading 0.0222 0.00807 0.00603 Inverse variance weighted 2 cis NA
Non-cancer illness code self-reported: depression -0.00472 0.00185 0.0106 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: depression -0.00472 0.00185 0.0106 Inverse variance weighted 2 cis NA
Neuroblastoma 0.945 0.394 0.0163 Wald ratio 1 trans NA
2hr glucose -0.132 0.0564 0.0197 Inverse variance weighted 2 trans NA
2hr glucose -0.132 0.0564 0.0197 Inverse variance weighted 2 cis NA
…and 213 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4498_62_2 NCAM-120 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

350 association rows across 195 traits (298 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating NCAM1 levels 2e-426 rs11214489 5 GCST90860446 no MR -> candidate analysis
ITGB1/NCAM1 protein level ratio 1e-415 rs17115160 1 GCST90315227 no MR -> candidate analysis
NCAM1 protein levels 1e-295 rs12804485 12 GCST90470003 no MR -> candidate analysis
Smoking initiation 9e-180 rs7935745 22 GCST90243985 no MR -> candidate analysis
CD16-CD56 on Natural Killer 7e-155 rs77291736 2 GCST90001884 no MR -> candidate analysis
Neural cell adhesion molecule 1, 120 kDa isoform levels 3e-73 rs11214489 5 GCST90248611 no MR -> candidate analysis
CD16-CD56 on Natural Killer T 9e-71 rs77738700 2 GCST90001883 no MR -> candidate analysis
Smoking initiation (ever regular vs never regular) (MTAG) 3e-61 rs2155646 1 GCST007468 no MR -> candidate analysis
Externalizing behaviour (multivariate analysis) 7e-59 rs9919558 1 GCST90061435 no MR -> candidate analysis
Blood protein levels 3e-54 rs11214489 2 GCST007128 no MR -> candidate analysis
Smoking status (ever vs never smokers) 7e-48 rs7938812 5 GCST007327 no MR -> candidate analysis
Smoking initiation (ever regular vs never regular) 9e-48 rs2155646 3 GCST007474 no MR -> candidate analysis
…and 183 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 2542 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
major depressive disorder 0.804 common-variant locus MR: beta=-0.117, p=0.256 (trans)
gastroesophageal reflux disease 0.809 common-variant locus no MR -> candidate analysis
smoking initiation 0.806 common-variant locus no MR -> candidate analysis
schizophrenia 0.724 common-variant locus MR: beta=-0.104, p=0.126 (trans)
Abdominal pain 0.743 common-variant locus MR: beta=-0.00166, p=0.451 (trans)
irritable bowel syndrome 0.737 common-variant locus no MR -> candidate analysis
post-traumatic stress disorder 0.708 common-variant locus no MR -> candidate analysis
Back pain 0.701 common-variant locus no MR -> candidate analysis
depressive disorder 0.68 common-variant locus MR: beta=-0.117, p=0.256 (trans)
brain injury 0.689 common-variant locus no MR -> candidate analysis
anorexia nervosa 0.686 common-variant locus MR: beta=-0.183, p=0.0649 (trans)
Cannabis use 0.684 common-variant locus no MR -> candidate analysis
mathematical ability 0.683 common-variant locus no MR -> candidate analysis
mood disorder 0.672 common-variant locus no MR -> candidate analysis
risk-taking behaviour 0.657 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 10 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 3 known modulators (Neural cell adhesion molecule 1)
gnomAD constraint pLI=1, LOEUF=0.199 — LoF-INTOLERANT
GWAS Catalog 185 unique SNPs / 430 rows
ClinVar 73 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx 1 clinical annotations across 1 drugs

Caveats declared by the tools

Sources

Provenance